Notes: 1) Observed values, no imputation for missing data. 2) Includes all participants who met the criteria for MetS at baseline and enough MetS component Week 13 data collected to determine MetS ...
PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that preclinical data on ARO-INHBE, an investigational RNAi-based medicine for the treatment of ...
Notes: Safety population, includes all randomized subjects who received at least one dose of study drug or placebo. 80 mg Cohort A = 60 mg daily x 1 wk, 80 mg daily x 3 wks; 80 mg Cohort B = 60 mg ...
Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...
Rhythm Pharmaceuticals announced significant data regarding their treatments for acquired hypothalamic obesity during the Endocrine Society’s Annual Meeting. Presentations highlighted the promising ...
Building on Proven Employer ROI and a Clinically Rigorous, Outcomes-Driven Obesity Program, Form Is Extending Its Industry-Leading Care Model to Employees With Diabetes Today, Form Health, the ...
Opinion
MedPage Today on MSNOpinion
Call to integrate obesity management with surgery, GLP-1s into cancer care
"Most effective therapies" underutilized, say authors, but oncologist cites lack of qualit ...
SAN DIEGO, Nov. 6, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results